See more
Does Sanofi have a patient assistance program?
Sanofi Patient Connection® is a program (the “Program”) to help you get access to the medications and resources you need at no cost. Patient Assistance Connection is part of the Program that provides select Sanofi prescription medications and vaccines, at no cost, if you meet certain eligibility requirements.
How can I get free Lovenox?
Enrollment forms can be obtained by accessing the website or by calling (888) 632-8607. Participants seeking Lovenox free of charge are required to complete a Patient Assistance Application. Signature from both the prescribing physician and patient are required.
How much is Lovenox a month?
Your monthly Lovenox cost savings if eligibleStrengthAvg. monthly price at a US pharmacyNiceRx monthly price150mg/ml 12 syringes$1,450.00$49.0030mg/0.3ml 12 syringes$320.00$49.0040mg/0.4ml 12 syringes$425.00$49.0060mg/0.6ml 12 syringes$599.00$49.003 more rows
How much is Lovenox out of pocket?
The cost for Lovenox injectable solution (30 mg/0.3 mL) is around $77 for a supply of 3 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Is there a generic version of Lovenox?
How is enoxaparin marketed? Enoxaparin is marketed under the brand name Lovenox and as a generic drug under the name enoxaparin sodium for injection. 4.
How much does enoxaparin cost without insurance?
How much does Enoxaparin Sodium cost without insurance? On average, uninsured customers can expect to pay $239.23 for Enoxaparin Sodium. However, $18.99 for 10, 10ml of 40mg/0.4ml Syringe is all you pay per prescription fill with a SingleCare Enoxaparin Sodium coupon.
Is Lovenox covered by Medicare Part D?
Yes. 100% of Medicare prescription drug plans cover this drug.
Who manufactures Lovenox?
No sooner did Sandoz begin shipments of the generic version, Sanofi-Aventis, manufacturer of Lovenox, filed a lawsuit to prevent the approval of the generic. Last year, Lovenox recorded $4.57 billion in sales for Sanofi-Aventis, according to IMS Health.